chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Red rash all over body, worse with heat,febrile On the 14th  a rash apppeared on abdomen 15th pt was irritable, 16th febrile 17th febrile and rash, 18th febrile and rash worse , By the 23rd patient rash completely cleared.
Pt experienced joint pain and fatigue.  Pt is unable to sleep at night and/or exercise from joint pain.
his brother received the Pfizer Covid-19 vaccine and got sick; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "his brother received the Pfizer Covid-19 vaccine and got sick".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE  ACUTE HYPOXEMIC RESPIRATORY FAILURE  10/10/2022 & 10/29/2023  --  RECURRENCE OF SAME SYMPTOMS
pt recvd vax 3DEC92 approx 7PM 2DEC92 had sz was taken to hosp; adm to hospital stayed 2 days; had x-rays & IV's; dx reaction to shots;
Edema in both hands, forearm and elbow region, right greater than left. Hypoxia and chest xray resulted with: RUL Infiltrate, WBC 12.39. Resident stated she didn't feel good . Resident has a cough and confusion. End stage renal failure, decreased voiding. Resident died 11/23/21.
about 15 minutes after the immunization the patient became unconscious. Vital signs stable. transported via EMS
heart began to race, throat felt swollen for at least 20 seconds, after shot- I began to concentrate and lower my breathing rate... I waited at least 20 minutes before I felt OK to leave with spouse. About 4:45 PM on my way home, while I was driving, i felt my tongue tingling, a weird taste, felt my chest beginning to tighten for a few seconds, felt headachy..  I took a Tylenol when I got home at 5:15 PM after taking my temp which registered 99F. I felt dizzy and drugged up for the next feew hours.
Case number PHEH2017US005204, is an initial spontaneous report received from a pharmacist on 16 Feb 2017. This report refers to a 62 years old female patient. Medical history was not reported. Concomitant medication was not reported. The pharmacist reported that, the temperature excursion was occurred in Jan for 10 hours, max temperature of 51.8 Fahrenheit and the patient was vaccinated with FLUCELVAX QUADRIVALENT (batch number: 186867, expiry date: May 2017) at a dose of 0.5 ml, intramuscularly on 13 Feb 2017, following the temperature excursion. No adverse event was reported following this medication error.
3/29: Heart palpitations, difficulty swallowing, tingling (face, shoulder, neck, arm), numbness in lips. April to Present: Heart palpitations, shortness of breath, chest pain, dizzy, nausea, lightheadedness.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administration expired vaccines) in a 42-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 059H21A) for COVID-19 vaccination. No Medical History information was reported. On 31-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 31-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administration expired vaccines). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administration expired vaccines) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial was initially stored in the refrigerator on 17 Mar 2022. The vials did not undergo any temperature excursion. No treatment medications were reported.
Information has been received from a medical assistant concerning a patient who was vaccinated with GARDASIL. It was reported that the patient missed a dose of GARDASIL due to quality issue with the prefilled syringe they had in stock. The patient missed the dose yesterday. The patient was already late for the second dose. Follow up information received from the medical assistant reported that the syringe (lot # 1423X) was empty. The MA placed the needle onto the hub and was holding on the trigger fingers and the spring released (user error). No leaking in the tray noted which was sealed. The plunger was all the way down and had no product in it. He reported he never touched the plunger. No product or drops seen in the plunger at all. The MA has been using the safety syringe for the past 3 years and was very familiar with it. All of the other 5 syringes are fine. On 01-JUL-2010 QA examined returned complaint sample and observed that the syringe was not locked into the safety device. In addition vaccine residue was observed on the stopper of the syringe. Therefore the empty code was changed to underfill and the code for assembled incorrectly was added. Additional information has been requested.
Vaccine administered beyond use date after the thaw process; This spontaneous case was reported by a paramedic and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered beyond use date after the thaw process) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027H21B) for COVID-19 prophylaxis.     It was unknown if patient ever been diagnosed with or tested positive for COVID-19. It was unknown if patient had acute illnesses at the time of vaccination and up to one month before. Unknown if patient had Chronic or long standing health conditions.     On 27-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 27-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered beyond use date after the thaw process). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered beyond use date after the thaw process) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient age was reported as 26 years and 8 months.  It was unknown that prescriptions, over the counter medications, dietary supplements, or herbal remedies being taken at time of vaccination or at the time of the adverse event.  The patient did not experienced any adverse reactions after the administration of vaccine.  No treatment medications were reported.
broke out in a really bad itchy rash allover my body; red bumps; some healing; some are scaring; This is a spontaneous report received from a non-contactable consumer, the patient via medical information team. A 49-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection) via unspecified route of administration on 21Mar2021 as a single dose for COVID-19 immunization. The patients medical history and concomitant medications were not reported. Had first Pfizer covid vaccine on 21Mar2021, a couple hours after vaccination in Mar2021, broke out in a really bad itchy rash all over my body that itchiness was really bad for first 24 to 36 hours, then continued to be itchy and stayed for a total of about 10 days, but continually got less and less, here we are a couple weeks out, still a few red bumps, some healing, some are scaring, all on an unknown date in Mar2021, concerned about getting the second shot. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Red, raised bumps all over legs, arms and groin on week after vaccination. Bumps are itchy and welt-like
This spontaneous report as received from a licensed practical nurse refers to a 57 year old patient. On 06-JAN-2017 the patient was vaccinated with a pediatric dose of RECOMBIVAX HB lot # M010212, expiration date 21-JAN-2019.   No adverse effect was reported. This is one of several reports from the same reporter.  Additional information has been requested.
Information has been received from a registered nurse concerning a 4 year old male who on 13-NOV-2002 was vaccinated with Varivax. In December 2002, the patient experienced shingles. Subsequently, the patient recovered from shingles. Additional information has been requested.
no adverse events at this time. I received covid vaccine - Pfizer- on 1/15/2021.  Received covid vaccine #2 on 2/5/2021. My Last menstrual period was Feb. 2, 2021. I am now pregnant. Just wanted to report this for data.
Left arm felt broke, no sleep 11:30p-6:30a couldn?t lift arm, pain was unbearable, fever 103, headache, chills, couldn?t get lift head up off pillow for 24 hours +, ran a fever of 100+ for 4/5 days. I had COVID-19 in August of 2020 & I was more sick after shot! Full blown Covid virus 2nd time, very scared to get 2nd dose. Each time I get Covid it affects my heart function.
Patient was administered the Covid-19 Pfizer Pediatric dose on 10/6/2022 at 7:06 PM as booster dose (0.2 mL). Patient was monitored for 15 minutes after injection. No adverse reaction noted at time of discharge. Patient left facility with no complaints or concerns. On the following day (10/7/2022), it was discovered by staff that the expiration date of the vaccine administered was 9/30/2022.
As soon as got shot felt spacey and had body aches  I could not go to work as restarting server that day. Did not feel well, exhausted and achey for rest of week. At arm injection site, skin flames in large rectangular patch 9 days after shot that went away after two days. I felt exhausted and achey for the rest of that week- 2 weeks after shot. And Started feeling head and gum pain that would not go away with over the counter meds. At 3 rd week after went to er for the pain and was diagnosed with  trigeminal neuralgia. I think vaccine had something to do with because of extra inflammation in body pressing against nerve.
This spontaneous report was received from a pharmacist, concerning a patient of unknown age gender. The patient's pertinent medical history, drug reactions/allergies were not provided. On 27-NOV-2013, at an unspecified nursing home, a patient received an expired dose of ZOSTAVAX (Lot # not provided and exact expiration date were not provided, but it was told by the nurse that the vaccine dose expired in September 2013). Co-suspect therapy and concomitant medications were not provided. No adverse effect was reported. Additional information is not expected.
May 2 2021- current Severe pain Leg nodules Pre-tibial bi-lateral myxedema Graves disease Hypothyroidism Chest pain  High blood pressure + more
pt recvd vax APR89; pt examined once by MD on 6APR92; pt had devel chronic arthritis of the knees, characterized by recurrent synvitis w/effusions; poss chronic rubella infect;
Severe sore arm at injection site (started 3 hours after injection; lasted ~36 hours) Body aches and pain (started ~18 hours after injection; lasted ~24 hours) Headache (started ~18 hours after injection; lasted ~24 hours) Fever (started about 21 hours after injection; lasted ~6 hours)
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unspecified age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications.   In 2016, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (dose, frequency, route of administration, anatomical location, lot number and expiration date were not provided) for the long-term prevention of shingles and zoster-related conditions.  Subsequent to the patient's inoculation, the patient was treated by the physician for shingles. As a direct and proximate result of patient's use of the zoster vaccine live (ZOSTAVAX) vaccine, the patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future.   At the time of the report, the outcome of shingles was considered as not recovered. The reporter considered herpes zoster to be related to Zoster Vaccine Live (ZOSTAVAX).
flu; Initial information was received on 29-Sep-2021 regarding an unsolicited valid non-serious case received from a consumer/non-health care professional via social media.  This case involves Adult male patient who experienced flu (Influenza) after receiving vaccine INFLUENZA VACCINE.  The patient's past vaccination included INFLUENZA VACCINE Quit getting the flu shot and have been fine since. Took it for 5 years and had the flu 4 out of five years that I had the shot.  It is unknown if the patient experienced any additional symptoms/events. Medication Details and reason for taking the medicine.  It is unknown if the patient had any medical history, concomitant disease or risk factor.   Medical treatment, concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious flu (influenza) (unknown latency) following the administration of INFLUENZA VACCINE.  It is unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  At the time of reporting, the outcome of events was reported as unknown.  There will be no information available on the batch number for this case.
I started sneezing and got a really runny nose. I had body aches and headaches. I have a cough. I was tested for COVID on 7/09/2021 and tested positive, and also tested positive for Influenza B.
The reaction was probably complicated by cellulitis she required an emergency visit with intravenous antibiotics, she's gotten steadily better on dicloxacillin since that time.  She has had no fever since her IV antibiotics.
I received my 3rd vaccination in my left arm.  After playing golf approximately 6 times and hitting about 500 golf balls at the driving range my left arm near where I received the vaccination became very very sore.  The soreness gets a little better after a day or so of not playing golf, but as soon as I play golf and hit about 50 golf balls at the driving range the soreness comes back.  Today I had my regular flu vaccination in my right arm.  I talked to the pharmacists and she thought I might have received my 3rd Covid  vaccination a little close to a nerve.  She recommended I file this form out.
Enlarged Spleen that started 48hrs after injection.  Still Enlarged as of 4/19, 14 days after vaccine Fatigue, malaise, weakness, heart palpitations and headaches for 10 days post vaccine.  Abnormal EKG 48 hrs after vaccine
Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and CHILLS (Chills) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Feb-2021, the patient experienced HEADACHE (Headache) and CHILLS (Chills). At the time of the report, HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.        No treatment information was provided.  No relevant concomitant medications were reported.    Reporter did not allow further contact
This was not an adverse event. Vaccine in freezer longer than 14 days. The patient advised to revaccinate. Re-vax 11/3/2021.
SERIOUSNESS CRITERIA: OTHER - MEDICALLY SIGNIFICANT.  Initial report received on 23 January 2008 from a health care professional.  A 7-year-old male patient, with no concurrent illnesses, and a history of allergies (allergies not defined) and asthma, had received a ninth, intramuscular, left arm dose of FLUZONE No Preservative 2007-2008 (lot number U2457HA) on 03 November 2007.  Eighty-one days after receiving the Fluzone vaccine, the patient developed a fever of 100.7 degrees Fahrenheit, watery eyes, congestion, cough, and sore throat.  A Quick Vue flu test positive for type A and B influenzae.  The patient was prescribed Tamiflu as treatment.  At the time of this report, the patient had not recovered.
RPH received phone call from mom today, 04/17/21, stating daugheter still has injection site pain after gettingr covid-19 vaccine on 4/2/21.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP). The reporter is the patient.  An elderly female patient (not pregnant) received BNT162b2 (BNT162B2), on 12Dec2020 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). Concomitant medication(s) included: AMLODIPINE, start date: 01Sep2010; LOSARTAN, start date: 01Sep2010; ESTRADIOL, start date: 01Sep2010.  The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Aug2022, outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19. Conclusion: This report was about covid treatment. The patient has received vaccine. The patient has received other medication in 2 weeks. Anti-viral details included Product=COVID 19 Treatment, brand=Paxlovid, on 30Aug2022 and treatment stopped on 03Sep2022 (Lot number=Unknown) for Treatment of COVID-19. Adverse event: Rebound headache sore throat aches chills nasal/sinus congestion cough on 08Sep2022 (Outcome: Not recovered, If treatment AE: No). Other medical history included Hypertension.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This is in follow-up to report(s) previously submitted on 7/15/2008. Information has been received from a certified medical assistant concerning a female who on 16-JUN-2008 was vaccinated with the first dose of GARDASIL vaccine (lot# 66039/1968U) at 10:30.. The patient had "trouble getting shots." Post vaccination the patient was monitored for approximately 15 minutes and when the patient walked around to check out window and passed out falling through the window. The patient was put into wheelchair and was given lemonade. The patient awoke and was responsive. On 16-JUN-2008 the patient recovered from faint. The patient sought medical attention at the office. This is one of several reports from the same source. Additional information ahs been requested.
Rash and hives from neck all the way to waist. Itchy rash covers the back and stomach as well. Very red and rash where injection was given but not the other arm. Very drowsy and unwell day after vaccine.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare providers recommended and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In 2013, a healthcare provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 31-JAN-2016, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Pain in her legs; Can't walk; Limited mobility; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in her legs), GAIT DISTURBANCE (Can't walk) and MOBILITY DECREASED (Limited mobility) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Pain in her legs), GAIT DISTURBANCE (Can't walk) and MOBILITY DECREASED (Limited mobility). The patient was treated with GABAPENTIN at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain in her legs) and MOBILITY DECREASED (Limited mobility) had not resolved and GAIT DISTURBANCE (Can't walk) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Jun-2022, SARS-CoV-2 test positive: Positive. On an unknown date, Blood test: Got blood tested but every test comes out fine.. On an unknown date, Magnetic resonance imaging: Patient had 8 MRIs.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient consulted visited 2 Neurologist,one Orthopedic specialist. Patient is an Athletic trainer and her mobility is so limited that it's hard to do her job. Concomitant medications was not provided by the reporter. Patient received a Moderna covid-19 vaccine and a month after she stated to feel pain in her legs and started to use crutches so that she can walk. Patient had no allergies. Treatment Crutches, Gluten Dairy and Sugar free diet, Homeopathic medicines, PT, Acupuncture were provided.
April 19.20- headache, body aches, fever, chills. April 21 to present - rash all over the body, itchy body and shortness of breath. The rash has not subsided, it has continued to spread throughout the body. Medications- Benadril 25mg every 6 hours, Zyrtec 10mg once a day.
Pt vaccinated with DTP experienced crying constantly for 24 hrs swelling on leg unable to be pacified.